A Risk Model Composed of Complete Blood Count, BRAF V600E and MAP2K1 Predicts Inferior Prognosis of Langerhans Cell Histiocytosis in Children. This evidence concerns the gene MAP2K1 and Langerhans cell histiocytosis.